A detailed history of Swiss National Bank transactions in Organon & Co. stock. As of the latest transaction made, Swiss National Bank holds 501,875 shares of OGN stock, worth $7.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
501,875
Previous 503,675 0.36%
Holding current value
$7.41 Million
Previous $10.4 Million 7.92%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$18.65 - $23.03 $33,570 - $41,454
-1,800 Reduced 0.36%
501,875 $9.6 Million
Q4 2023

Feb 06, 2024

SELL
$10.95 - $17.32 $624,150 - $987,240
-57,000 Reduced 10.17%
503,675 $7.26 Million
Q3 2023

Nov 08, 2023

BUY
$16.59 - $23.77 $112,812 - $161,636
6,800 Added 1.23%
560,675 $9.73 Million
Q2 2023

Aug 09, 2023

BUY
$19.27 - $24.63 $94,423 - $120,687
4,900 Added 0.89%
553,875 $11.5 Million
Q1 2023

May 10, 2023

SELL
$21.42 - $32.08 $1.4 Million - $2.09 Million
-65,200 Reduced 10.62%
548,975 $12.9 Million
Q4 2022

Feb 08, 2023

BUY
$23.31 - $28.61 $296,037 - $363,347
12,700 Added 2.11%
614,175 $17.2 Million
Q3 2022

Nov 09, 2022

BUY
$23.4 - $34.25 $98,280 - $143,850
4,200 Added 0.7%
601,475 $14.1 Million
Q2 2022

Aug 09, 2022

SELL
$31.66 - $38.9 $69,652 - $85,580
-2,200 Reduced 0.37%
597,275 $20.2 Million
Q1 2022

May 09, 2022

BUY
$30.45 - $39.36 $1.26 Million - $1.63 Million
41,500 Added 7.44%
599,475 $20.9 Million
Q4 2021

Feb 08, 2022

SELL
$28.67 - $37.13 $34,404 - $44,556
-1,200 Reduced 0.21%
557,975 $17 Million
Q3 2021

Nov 08, 2021

SELL
$28.63 - $35.64 $57,260 - $71,280
-2,000 Reduced 0.36%
559,175 $18.3 Million
Q2 2021

Aug 06, 2021

BUY
$28.45 - $38.0 $16 Million - $21.3 Million
561,175 New
561,175 $17 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.